Stephen P. Colegate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephen P. Colegate has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Cole Brokamp
Cincinnati Children’s Hospital Medical Center
2 shared publications- Emrah Gecili
Affiliations Division of Biostatistics & Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, United States of America
2 shared publications Rhonda D. Szczesniak
Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, United States
2 shared publicationsAaron Flicker
Cincinnati Children’s Hospital Medical Center
1 shared publicationAndrew F. Beck
University of Cincinnati College of Medicine
1 shared publication- Andrew Finkel Beck
Division of Hospital Medicine Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA
1 shared publication
Latest Publications
- Open Access
- 24 January 2026
- Published by Elsevier in Atmospheric Environment: X
- Vol. 29
Acute exposure to fine ambient particulate matter and pulmonary exacerbations in cystic fibrosis: A case-crossover study
- 24 January 2026
- Published by Elsevier in Atmospheric Environment: X
- Vol. 29
Open AccessAcute exposure to fine ambient particulate matter and pulmonary exacerbations in cystic fibrosis: A case-crossover study
- Open Access
- 30 July 2025
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 9 (1) , e185
Formulating and evaluating time series algorithms to forecast daily asthma hospital admissions
Introduction: Asthma exacerbations are frequent causes of pediatric hospital admissions. We sought to develop a time series algorithm to forecast next-day daily asthma hospitalizations. Methods: Daily hospitalizations for asthma were collected at Cincinnati Children’s from January 1, 2016, to December 31, 2023. We evaluated Autoregressive Integrated Moving Average (ARIMA), Exponential Smoothing (ETS), Prophet, and Ensemble models to forecast next-day asthma hospitalizations validated on 2023 data, considering varying historical training data lengths. Forecasts were calibrated to identify days exceeding a 5% high-risk threshold of historical totals and considered multiple validation years and years before and during the COVID-19 pandemic. Results: A total of 5,593 hospital admissions were recorded for asthma. Over 2,922 days, 166 days met the 5% high-risk threshold equating to 6 or more admissions. The Ensemble (Median Absolute Percentage Error (MAPE): 46.7%; Positive Predictive Value (PPV): 0.278; Negative Predictive Value (NPV): 0.942; Area Under the ROC Curve (AUC): 0.740; Sensitivity: 0.800; Specificity: 0.656) model achieved higher accuracy of high-risk days than ARIMA (MAPE: 46.5%; PPV: 0.278; NPV: 0.942; AUC: 0.709; Sensitivity: 0.760; Specificity: 0.571), ETS (MAPE: 47.2%; PPV: 0.222; NPV: 0.939; AUC: 0.711; Sensitivity: 0.800; Specificity: 0.668), and Prophet (MAPE: 48.9%; PPV: 0.444; NPV: 0.951; AUC: 0.732; Sensitivity: 0.680; Specificity: 0.741) models. Conclusions: Our Ensemble model of mean predictions from ARIMA, ETS, and Prophet models was the most accurate in forecasting future asthma hospitalizations. Integrating forecasting techniques with clinical operations could enable proactive prevention through enhanced population care management.
- 30 July 2025
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 9 (1) , e185
Open AccessFormulating and evaluating time series algorithms to forecast daily asthma hospital admissions
Introduction: Asthma exacerbations are frequent causes of pediatric hospital admissions. We sought to develop a time series algorithm to forecast next-day daily asthma hospitalizations. Methods: Daily hospitalizations for asthma were collected at Cincinnati Children’s from January 1, 2016, to December 31, 2023. We evaluated Autoregressive Integrated Moving Average (ARIMA), Exponential Smoothing (ETS), Prophet, and Ensemble models to forecast next-day asthma hospitalizations validated on 2023 data, considering varying historical training data lengths. Forecasts were calibrated to identify days exceeding a 5% high-risk threshold of historical totals and considered multiple validation years and years before and during the COVID-19 pandemic. Results: A total of 5,593 hospital admissions were recorded for asthma. Over 2,922 days, 166 days met the 5% high-risk threshold equating to 6 or more admissions. The Ensemble (Median Absolute Percentage Error (MAPE): 46.7%; Positive Predictive Value (PPV): 0.278; Negative Predictive Value (NPV): 0.942; Area Under the ROC Curve (AUC): 0.740; Sensitivity: 0.800; Specificity: 0.656) model achieved higher accuracy of high-risk days than ARIMA (MAPE: 46.5%; PPV: 0.278; NPV: 0.942; AUC: 0.709; Sensitivity: 0.760; Specificity: 0.571), ETS (MAPE: 47.2%; PPV: 0.222; NPV: 0.939; AUC: 0.711; Sensitivity: 0.800; Specificity: 0.668), and Prophet (MAPE: 48.9%; PPV: 0.444; NPV: 0.951; AUC: 0.732; Sensitivity: 0.680; Specificity: 0.741) models. Conclusions: Our Ensemble model of mean predictions from ARIMA, ETS, and Prophet models was the most accurate in forecasting future asthma hospitalizations. Integrating forecasting techniques with clinical operations could enable proactive prevention through enhanced population care management.
- 6 September 2024
- Published by Elsevier in Annals of Epidemiology
- Vol. 97, 120
Integrating a machine learning algorithm to forecast daily asthma hospitalizations
- 6 September 2024
- Published by Elsevier in Annals of Epidemiology
- Vol. 97, 120
Integrating a machine learning algorithm to forecast daily asthma hospitalizations
- Open Access
- 7 May 2024
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 8 (1) , e94
Evaluating precision medicine tools in cystic fibrosis for racial and ethnic fairness
Introduction: Patients with cystic fibrosis (CF) experience frequent episodes of acute decline in lung function called pulmonary exacerbations (PEx). An existing clinical and place-based precision medicine algorithm that accurately predicts PEx could include racial and ethnic biases in clinical and geospatial training data, leading to unintentional exacerbation of health inequities. Methods: We estimated receiver operating characteristic curves based on predictions from a nonstationary Gaussian stochastic process model for PEx within 3, 6, and 12 months among 26,392 individuals aged 6 years and above (2003–2017) from the US CF Foundation Patient Registry. We screened predictors to identify reasons for discriminatory model performance. Results: The precision medicine algorithm performed worse predicting a PEx among Black patients when compared with White patients or to patients of another race for all three prediction horizons. There was little to no difference in prediction accuracies among Hispanic and non-Hispanic patients for the same prediction horizons. Differences in F508del, smoking households, secondhand smoke exposure, primary and secondary road densities, distance and drive time to the CF center, and average number of clinical evaluations were key factors associated with race. Conclusions: Racial differences in prediction accuracies from our PEx precision medicine algorithm exist. Misclassification of future PEx was attributable to several underlying factors that correspond to race: CF mutation, location where the patient lives, and clinical awareness. Associations of our proxies with race for CF-related health outcomes can lead to systemic racism in data collection and in prediction accuracies from precision medicine algorithms constructed from it.
- 7 May 2024
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 8 (1) , e94
Open AccessEvaluating precision medicine tools in cystic fibrosis for racial and ethnic fairness
Introduction: Patients with cystic fibrosis (CF) experience frequent episodes of acute decline in lung function called pulmonary exacerbations (PEx). An existing clinical and place-based precision medicine algorithm that accurately predicts PEx could include racial and ethnic biases in clinical and geospatial training data, leading to unintentional exacerbation of health inequities. Methods: We estimated receiver operating characteristic curves based on predictions from a nonstationary Gaussian stochastic process model for PEx within 3, 6, and 12 months among 26,392 individuals aged 6 years and above (2003–2017) from the US CF Foundation Patient Registry. We screened predictors to identify reasons for discriminatory model performance. Results: The precision medicine algorithm performed worse predicting a PEx among Black patients when compared with White patients or to patients of another race for all three prediction horizons. There was little to no difference in prediction accuracies among Hispanic and non-Hispanic patients for the same prediction horizons. Differences in F508del, smoking households, secondhand smoke exposure, primary and secondary road densities, distance and drive time to the CF center, and average number of clinical evaluations were key factors associated with race. Conclusions: Racial differences in prediction accuracies from our PEx precision medicine algorithm exist. Misclassification of future PEx was attributable to several underlying factors that correspond to race: CF mutation, location where the patient lives, and clinical awareness. Associations of our proxies with race for CF-related health outcomes can lead to systemic racism in data collection and in prediction accuracies from precision medicine algorithms constructed from it.